SE9702534D0 - Compounds - Google Patents

Compounds

Info

Publication number
SE9702534D0
SE9702534D0 SE9702534A SE9702534A SE9702534D0 SE 9702534 D0 SE9702534 D0 SE 9702534D0 SE 9702534 A SE9702534 A SE 9702534A SE 9702534 A SE9702534 A SE 9702534A SE 9702534 D0 SE9702534 D0 SE 9702534D0
Authority
SE
Sweden
Prior art keywords
pct
sec
compounds
date
date aug
Prior art date
Application number
SE9702534A
Other languages
English (en)
Inventor
Peter Hamley
Austen Pimm
Alan Tinker
Original Assignee
Astra Pharma Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Pharma Prod filed Critical Astra Pharma Prod
Priority to SE9702534A priority Critical patent/SE9702534D0/sv
Publication of SE9702534D0 publication Critical patent/SE9702534D0/sv
Priority to ZA985326A priority patent/ZA985326B/xx
Priority to ARP980102919A priority patent/AR013004A1/es
Priority to EEP199900602A priority patent/EE9900602A/xx
Priority to PCT/SE1998/001206 priority patent/WO1999001455A1/en
Priority to IL13372998A priority patent/IL133729A0/xx
Priority to BR9810214-1A priority patent/BR9810214A/pt
Priority to AU81356/98A priority patent/AU729792B2/en
Priority to PL98337536A priority patent/PL337536A1/xx
Priority to CN98808429A priority patent/CN1268138A/zh
Priority to HU0003104A priority patent/HUP0003104A3/hu
Priority to EP98931170A priority patent/EP1000064A1/en
Priority to CA002294734A priority patent/CA2294734A1/en
Priority to SK1702-99A priority patent/SK170299A3/sk
Priority to JP50700699A priority patent/JP2002507987A/ja
Priority to TR1999/03296T priority patent/TR199903296T2/xx
Priority to IDW991642A priority patent/ID25585A/id
Priority to US09/125,174 priority patent/US6083952A/en
Priority to KR1019997012524A priority patent/KR20010014367A/ko
Priority to IS5323A priority patent/IS5323A/is
Priority to NO996544A priority patent/NO996544L/no
Priority to US09/583,775 priority patent/US6211189B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/20—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/20—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed systems contains four or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE9702534A 1997-07-01 1997-07-01 Compounds SE9702534D0 (sv)

Priority Applications (22)

Application Number Priority Date Filing Date Title
SE9702534A SE9702534D0 (sv) 1997-07-01 1997-07-01 Compounds
ZA985326A ZA985326B (en) 1997-07-01 1998-06-18 Aminospiropiperidine quinazoline derivatives
ARP980102919A AR013004A1 (es) 1997-07-01 1998-06-18 Derivados de aminospiropiperidina quinazolina, composicion farmaceutica, uso de dichos derivados en la preparacion de medicamentos, proceso para lapreparacion de dichos derivados y compuestos intermediarios para su exclusivo uso en dicho proceso.
KR1019997012524A KR20010014367A (ko) 1997-07-01 1998-06-22 화합물
HU0003104A HUP0003104A3 (en) 1997-07-01 1998-06-22 Amino-spiropiperidin-quinazoline derivatives, their use, process for their preparation and pharmaceutical compositions containing them
CA002294734A CA2294734A1 (en) 1997-07-01 1998-06-22 Compounds
IL13372998A IL133729A0 (en) 1997-07-01 1998-06-22 Compounds
BR9810214-1A BR9810214A (pt) 1997-07-01 1998-06-22 Composto, composição farmacêutica, uso de um composto, e, processos para tratar ou reduzir o risco de doenças ou condições humanas, para tratar ou reduzir o risco de doença inflamatória e de dor em uma pessoa sofrendo de ou sob risco de dita doença, de tratamento, e para a preparação de um composto
AU81356/98A AU729792B2 (en) 1997-07-01 1998-06-22 Compounds
PL98337536A PL337536A1 (en) 1997-07-01 1998-06-22 Chemical compounds
CN98808429A CN1268138A (zh) 1997-07-01 1998-06-22 化合物
EEP199900602A EE9900602A (et) 1997-07-01 1998-06-22 Ühendid
EP98931170A EP1000064A1 (en) 1997-07-01 1998-06-22 Compounds
PCT/SE1998/001206 WO1999001455A1 (en) 1997-07-01 1998-06-22 Compounds
SK1702-99A SK170299A3 (en) 1997-07-01 1998-06-22 Aminospiro piperidine quinazoline derivatives, process and intermediates to their preparation, pharmaceutical compositions them containing and their use
JP50700699A JP2002507987A (ja) 1997-07-01 1998-06-22 化合物
TR1999/03296T TR199903296T2 (en) 1997-07-01 1998-06-22 Bile�ikler.
IDW991642A ID25585A (id) 1997-07-01 1998-06-22 Senyawa-senyawa
US09/125,174 US6083952A (en) 1997-07-01 1998-06-22 Compounds
IS5323A IS5323A (is) 1997-07-01 1999-12-28 Efnasambönd
NO996544A NO996544L (no) 1997-07-01 1999-12-29 Forbindelser
US09/583,775 US6211189B1 (en) 1997-07-01 2000-05-31 Amino-spiro-quinazoline compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9702534A SE9702534D0 (sv) 1997-07-01 1997-07-01 Compounds

Publications (1)

Publication Number Publication Date
SE9702534D0 true SE9702534D0 (sv) 1997-07-01

Family

ID=20407595

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9702534A SE9702534D0 (sv) 1997-07-01 1997-07-01 Compounds

Country Status (21)

Country Link
US (2) US6083952A (sv)
EP (1) EP1000064A1 (sv)
JP (1) JP2002507987A (sv)
KR (1) KR20010014367A (sv)
CN (1) CN1268138A (sv)
AR (1) AR013004A1 (sv)
AU (1) AU729792B2 (sv)
BR (1) BR9810214A (sv)
CA (1) CA2294734A1 (sv)
EE (1) EE9900602A (sv)
HU (1) HUP0003104A3 (sv)
ID (1) ID25585A (sv)
IL (1) IL133729A0 (sv)
IS (1) IS5323A (sv)
NO (1) NO996544L (sv)
PL (1) PL337536A1 (sv)
SE (1) SE9702534D0 (sv)
SK (1) SK170299A3 (sv)
TR (1) TR199903296T2 (sv)
WO (1) WO1999001455A1 (sv)
ZA (1) ZA985326B (sv)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002073760A (ja) * 2000-08-28 2002-03-12 Tadakatsu Yoshida 貿易統合システム
US7189851B2 (en) * 2002-03-06 2007-03-13 Smithkline Beecham Corporation Condensed heterocyclic compounds as calcitonin agonists
US20040063751A1 (en) * 2002-05-31 2004-04-01 Pharmacia Corporation Combination therapy for the treatment of amyotrophic lateral sclerosis (ALS) with cyclooxygenase-2 (COX-2) inhibitor(s) and a second drug
CN112225662A (zh) * 2020-11-16 2021-01-15 苏州华鑫医药科技有限公司 一种邻碘苯甲酸的制备方法
US20240165148A1 (en) 2021-03-15 2024-05-23 Saul Yedgar Hyaluronic acid-conjugated dipalmitoyl phosphatidyl ethanolamine in combination with non-steroidal anti-inflammatory drugs (nsaids) for treating or alleviating inflammatory diseases
CN114773316B (zh) * 2022-06-17 2022-10-25 上海睿跃生物科技有限公司 2-(2,6-二氧代-哌啶-3-基)-5-氟-异吲哚-1,3-二酮的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3761480A (en) * 1968-07-10 1973-09-25 Pennwalt Corp Process for the preparation of 3-aryl-6-sulfamyl-7-halo-1,2,3,4-tetrahydro-4-quinazolinones
CZ119398A3 (cs) * 1995-10-17 1998-09-16 Astra Aktiebolag Farmaceuticky účinné sloučeniny na bázi chinazolinu

Also Published As

Publication number Publication date
NO996544D0 (no) 1999-12-29
AR013004A1 (es) 2000-11-22
EP1000064A1 (en) 2000-05-17
BR9810214A (pt) 2000-08-08
CN1268138A (zh) 2000-09-27
ZA985326B (en) 1999-03-23
US6083952A (en) 2000-07-04
IL133729A0 (en) 2001-04-30
AU8135698A (en) 1999-01-25
AU729792B2 (en) 2001-02-08
SK170299A3 (en) 2000-08-14
IS5323A (is) 1999-12-28
CA2294734A1 (en) 1999-01-14
NO996544L (no) 2000-02-29
ID25585A (id) 2000-10-19
KR20010014367A (ko) 2001-02-26
US6211189B1 (en) 2001-04-03
TR199903296T2 (en) 2000-07-21
WO1999001455A1 (en) 1999-01-14
JP2002507987A (ja) 2002-03-12
HUP0003104A3 (en) 2002-01-28
PL337536A1 (en) 2000-08-28
EE9900602A (et) 2000-08-15
HUP0003104A2 (hu) 2001-02-28

Similar Documents

Publication Publication Date Title
HUP0004559A1 (hu) Ciklinfüggő kinázok aminotiazol inhibitorai, az ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
HUP0202795A2 (hu) Pirimidin- és pirazinszármazékok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
MXPA03010142A (es) Nuevos derivados de arilheteroalquilamina.
HUP0400365A2 (hu) 3-Fluor-pirrolidinek, mint cukorbetegség elleni szerek és a vegyületeket tartalmazó gyógyszerkészítmények
HUP9901820A2 (hu) 4-Amino-pirimidin-származékok, ezeket tartalmazó gyógyszerkészítmények, alkalmazásuk és eljárás előállításukra
NO20060146L (no) Benzimidazolderivater, sammensetninger som inneholder slike, fremstilling derav og anvendelse derav
HUP0401104A2 (hu) Dipeptidil-peptidáz inhibitorként cukorbetegség megelőzésére és kezelésére alkalmazható (béta-aminoacil)-tetrahidroimidazo[1,2-a]pirazinok és - tetrahidrotriazolo[4,3-a]pirazinok, valamint az ezeket tartalmazó gyógyszerkészítmények
ATE402174T1 (de) Imidazopyridinderivate als kinaseinhibitoren
HUP0105414A2 (hu) Pirrolo-izokinolin-, azepino- és diazepino-indol-származékok, alkalmazásuk és az ezeket tartalmazó gyógyszerkészítmények
SE9701304D0 (sv) Compounds
HUP0402352A2 (hu) Foszfodiészteráz (PDE) 7 inhibitorként alkalmazható pirimidinszármazékok és ezeket tartalmazó gyógyszerkészítmények
NO20060147L (no) Benzimidazolderivater, sammensetninger som inneholder slike, fremstilling derav og anvendelse derav
ATE228507T1 (de) Substituierte 6-phenylphenanthridine
SE9803518D0 (sv) Novel compounds
ES2098947T3 (es) Derivados de beta,beta-dimetil-4-piperidinoetanamina como inhibidores de la biosintesis del colesterol.
HUP0301032A2 (hu) Ciklin-dependens kinázok N-{5-[(5-alkil-2-oxazolil)-metil-tio]-2-tiazolil}-karboxamid inhibitorai, alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények
SE0104250D0 (sv) Heterocyclic compounds
ES2135769T3 (es) Derivados de isotiourea como inhibidores de no-sintasa.
DE60220055D1 (de) 4-(4-methoxybenzyl)-n'-(5-nitro-1,3-thiazol-2-yl)harnstoff und dessen verwendung bei der behandlung von mit glycogensynthasekinase-3 (gsk3) assoziierten leiden
SE9803773D0 (sv) Compounds
SE9702534D0 (sv) Compounds
NO20022123L (no) Osoksazolderivater for anvendelse som inhibitorer for fosfodiesterase VII
ATE265423T1 (de) Neue phenylheteroalkylamin-derivate
SE0102641D0 (sv) Novel compounds
SE9701396D0 (sv) Compounds